kidney

Learn About Kidney and Bladder Cancer On Webcast

by

OSUWexnerbloglogo2014 Learn About Kidney and Bladder Cancer On Webcast. Today, nephrectomies are commonly performed to treat kidney cancer as well as other conditions. On this webcast, we will hear from two of Ohio State University Wexner Medical Center & James Cancer Hospital’s Urologic surgeons on the treatment of both kidney and bladder cancers. We’re delighted to introduce Assistant Professor of Urology Dr Debashish Sundi and Associate Professor of Urology Dr Geoffrey Box.

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: recognize how to evaluate hematuria, including when to refer for cystoscopy and upper urinary tract imaging; describe how bladder cancer treatments vary widely based on stage and grade; describe the treatment options for kidney cancer; and describe the appropriate radiographic evaluation of a renal mass.

You’ll also learn about the following:

  • Imaging
  • Tests prior to referral
  • Stage at diagnosis
  • Screening for kidney cancer
  • Prevention

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

CME Webast Teaches On Chronic Kidney Disease

by

OSUWexnerbloglogo2014 CME Webast Teaches On Chronic Kidney Disease. Now, dialysis has become so commonplace that we now consider it to be a routine treatment in nearly every hospital in the country. But more importantly, we now have treatments that can hold kidney failure in check and often prevent the need for dialysis. Today on MedNet, we are going to take a look at some of these new developments in the management of chronic kidney disease. I’m please to introduce today’s guest. Dr. Khaled Boubes is nephrologist and Assistant Professor of Internal Medicine at the Ohio State University.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: recognize the prevalence and importance of CKD; and realize the importance and effectiveness of SGLT2-inhibitors in halting the progression of CKD.

You’ll also learn about the following:

  • Causes of chronic kidney disease
  • New treatments for chronic kidney disease
  • Diet and chronic kidney disease
  • Blood pressure management in chronic kidney disease
  • Anti-hypertensive medication selection in chronic kidney disease
  • Acute dialysis indications
  • Chronic dialysis indications
  • Options for dialysis

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.